Top-level recognition: Vladimir Putin awarded the Director of Investment Development of JSC Biochemist

Tatiana Lysova, Director of Investment Development at JSC Biochemist, was awarded the medal of the Order of Merit for the Fatherland, II degree. The corresponding decree was signed by the President of Russia on June 24, 2025.

Tatiana Nikolaevna has been working at Biochemistry for 40 years. During this time, she has worked a long way – from a microbiologist laboratory assistant to a Director of Investment Development. Under her leadership, the most important projects were implemented, thanks to which production expanded, advanced technologies were introduced and the quality of PROMOMED products improved.

"It is a great honor to receive such a high award. I am sincerely grateful to every employee of our company for their contribution to the overall success. We will continue to work together to develop our Company and strengthen the position of the domestic pharmaceutical industry," said Tatiana Lysova.

JSC Biochemist is a part of PROMOMED Company. The company implements the concept of a full production cycle "from Idea to Molecule, from Molecule to Patient." Currently, more than 350 drugs are produced here in such therapeutic areas as endocrinology, oncology, neurology, autoimmune diseases, infection control, acute and chronic pain, etc. Among the drugs are such blockbusters as Tirzetta®, Velgia®, Velgia® Eco, Quintenta®, Esperavir®, etc. Due to its own innovative chemical technologies and biotechnologies, as well as modern production facilities, PROMOMED is an active participant in the system of ensuring national drug safety and import independence of the country.